Sulbactam/durlobactam

< Sulbactam

Sulbactam/durlobactam
Combination of
Sulbactambeta-lactam antibacterial, beta-lactamase inhibitor
Durlobactambeta-lactamase inhibitor
Clinical data
Trade namesXacduro
License data
Routes of
administration		Intravenous
ATC code
  • None
Legal status
Legal status
Identifiers
KEGG

Sulbactam/durlobactam, sold under the brand name Xacduro (by Innoviva Specialty Therapeutics), is a co-packaged medication used for the treatment of bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus complex. It contains sulbactam, a beta-lactam antibacterial and beta-lactamase inhibitor; and durlobactam, a beta-lactamase inhibitor.

Sulbactam/durlobactam was approved for medical use in the United States in May 2023.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.